21 related articles for article (PubMed ID: 8674961)
1. [THE COMPLEX TREATMENT OF FEMALE STERILITY].
SHAIPOVA NA
Med Zh Uzb; 1964 Jan; 1():26-8. PubMed ID: 14150126
[No Abstract] [Full Text] [Related]
2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
5. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
6. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
[TBL] [Abstract][Full Text] [Related]
7. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.
Fauser BC; Devroey P; Yen SS; Gosden R; Crowley WF; Baird DT; Bouchard P
Hum Reprod; 1999 Nov; 14(11):2681-6. PubMed ID: 10548600
[No Abstract] [Full Text] [Related]
8. Ovarian programming and GIFT.
Rolet F; Gadaud S; Zorn JR; Boyer P; Guichard A; Cedard L
Hum Reprod; 1988 May; 3(4):563-5. PubMed ID: 3292575
[TBL] [Abstract][Full Text] [Related]
9. [Highly purified FSH for stimulation of down regulated cycles in the in vitro fertilization program].
Sydow P; Lisse K; Schürenkämper P; Scheiber I; Bloechle M
Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):146-50. PubMed ID: 8674961
[TBL] [Abstract][Full Text] [Related]
10. Significance of premature progesterone rise in IVF.
Fatemi HM; Van Vaerenbergh I
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):242-8. PubMed ID: 25811257
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
